Project Details
Description
An 8 week, placebo controlled, double blind, randomized, fixed dose efficacy and safety trial of asenapine in adolescent subject with schizophrenia (Protocol No, P05896)
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/11 → 4/1/13 |
Funding
- SCHERING-PLOUGH CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.